422 related articles for article (PubMed ID: 23957390)
1. Discovery of HIV-1 integrase inhibitors: pharmacophore mapping, virtual screening, molecular docking, synthesis, and biological evaluation.
Bhatt H; Patel P; Pannecouque C
Chem Biol Drug Des; 2014 Feb; 83(2):154-66. PubMed ID: 23957390
[TBL] [Abstract][Full Text] [Related]
2. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
[TBL] [Abstract][Full Text] [Related]
3. Discovery of HIV-1 integrase inhibitors by pharmacophore searching.
Hong H; Neamati N; Wang S; Nicklaus MC; Mazumder A; Zhao H; Burke TR; Pommier Y; Milne GW
J Med Chem; 1997 Mar; 40(6):930-6. PubMed ID: 9083481
[TBL] [Abstract][Full Text] [Related]
4. Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase.
Dayam R; Sanchez T; Neamati N
J Med Chem; 2005 Dec; 48(25):8009-15. PubMed ID: 16335925
[TBL] [Abstract][Full Text] [Related]
5. Structural modifications of 5,6-dihydroxypyrimidines with anti-HIV activity.
Guo DL; Zhang XJ; Wang RR; Zhou Y; Li Z; Xu JY; Chen KX; Zheng YT; Liu H
Bioorg Med Chem Lett; 2012 Dec; 22(23):7114-8. PubMed ID: 23099098
[TBL] [Abstract][Full Text] [Related]
6. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of N-methylpyrimidone derivatives as HIV-1 integrase inhibitors.
Wang Y; Rong J; Zhang B; Hu L; Wang X; Zeng C
Bioorg Med Chem; 2015 Feb; 23(4):735-41. PubMed ID: 25618597
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential HIV-1 integrase strand transfer inhibitors: in silico virtual screening and QM/MM docking studies.
Reddy KK; Singh SK; Tripathi SK; Selvaraj C
SAR QSAR Environ Res; 2013; 24(7):581-95. PubMed ID: 23521430
[TBL] [Abstract][Full Text] [Related]
9. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
[TBL] [Abstract][Full Text] [Related]
10. Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor.
Quashie PK; Han YS; Hassounah S; Mesplède T; Wainberg MA
PLoS One; 2015; 10(6):e0128310. PubMed ID: 26046987
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75.
De Luca L; Barreca ML; Ferro S; Christ F; Iraci N; Gitto R; Monforte AM; Debyser Z; Chimirri A
ChemMedChem; 2009 Aug; 4(8):1311-6. PubMed ID: 19565598
[TBL] [Abstract][Full Text] [Related]
12. Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors.
Barreca ML; Ferro S; Rao A; De Luca L; Zappalà M; Monforte AM; Debyser Z; Witvrouw M; Chimirri A
J Med Chem; 2005 Nov; 48(22):7084-8. PubMed ID: 16250669
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel β-diketo derivatives as HIV-1 integrase inhibitors.
Hu L; Zhang S; He X; Luo Z; Wang X; Liu W; Qin X
Bioorg Med Chem; 2012 Jan; 20(1):177-82. PubMed ID: 22154762
[TBL] [Abstract][Full Text] [Related]
14. Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.
Neamati N; Hong H; Mazumder A; Wang S; Sunder S; Nicklaus MC; Milne GW; Proksa B; Pommier Y
J Med Chem; 1997 Mar; 40(6):942-51. PubMed ID: 9083483
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and anti-HIV activity of novel quinoxaline derivatives.
Patel SB; Patel BD; Pannecouque C; Bhatt HG
Eur J Med Chem; 2016 Jul; 117():230-40. PubMed ID: 27105027
[TBL] [Abstract][Full Text] [Related]
16. Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase.
Verschueren WG; Dierynck I; Amssoms KI; Hu L; Boonants PM; Pille GM; Daeyaert FF; Hertogs K; Surleraux DL; Wigerinck PB
J Med Chem; 2005 Mar; 48(6):1930-40. PubMed ID: 15771437
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site.
Wielens J; Headey SJ; Jeevarajah D; Rhodes DI; Deadman J; Chalmers DK; Scanlon MJ; Parker MW
FEBS Lett; 2010 Apr; 584(8):1455-62. PubMed ID: 20227411
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel HIV-1 integrase inhibitors using shape-based screening, QSAR, and docking approach.
Gupta P; Garg P; Roy N
Chem Biol Drug Des; 2012 May; 79(5):835-49. PubMed ID: 22233531
[TBL] [Abstract][Full Text] [Related]
19. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
[TBL] [Abstract][Full Text] [Related]
20. Combined ligand and structure-based approaches on HIV-1 integrase strand transfer inhibitors.
Reddy KK; Singh SK
Chem Biol Interact; 2014 Jul; 218():71-81. PubMed ID: 24792351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]